Hepatocellular carcinoma: Patients with increasing alpha-fetoprotein but no mass on ultrasound

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 1, 2006, Pages 29-35

  Llovet, Josep M ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BILIRUBIN; BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; GAMMA GLUTAMYL HYDROLASE; GLYPICAN; HEAT SHOCK PROTEIN 70; PHOSPHOLIPASE A2; SOMATOMEDIN;

ALBUMIN BLOOD LEVEL; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ECHOGRAPHY; HEALTH CARE ORGANIZATION; HEMODIALYSIS; HEPATITIS C VIRUS; HEPATOMEGALY; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PHYSICAL EXAMINATION; PORTAL VEIN BLOOD FLOW; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; REVIEW; SPLENOMEGALY; TREATMENT RESPONSE; ULTRASOUND;

EID: 31144453013     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00864-5     Document Type: Article

References (14)

1. J.M. Llovet A. Burroughs J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
2. J. Bruix M. Sherman J.M. Llovet Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 35 2001 421 430
3. J.M. Llovet M. Beaugrand Hepatocellular carcinoma present status and future prospects J Hepatol 38 2003 S136 S149
4. M. Sherman Alpha fetoprotein an obituary J Hepatol 34 2001 603 605
5. S. Gupta S. Bent J. Kohlwes Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C Ann Intern Med 139 2003 46 50
6. F. Trevisani P. D’Intino Morselli-Labate Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease influence of HbsAg and anti-HCV status J Hepatol 34 2001 570 575
7. R. Lencioni D. Cioni L. Crocetti Magnetic resonance imaging of liver tumors J Hepatol 40 2004 162 171
8. R.F. Velazquez M. Rodriguez C.A. Navascues Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 2003 520 527
9. J. Bruix J.M. Llovet HCC surveillance who is the target population? Hepatology 37 2003 507 509
10. M. Sherman K.M. Peltekian C. Lee Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus incidence and prevalence of hepatocellular carcinoma in a North American urban population Hepatology 22 1995 432 438
11. J. Marrero A. Lok New markers for hepatocellular carcinoma Gastroenterology 127 2004 S113 S119
12. M. Burrel J.M. Llovet C. Ayuso MRI angiography is superior to triphasic helical CT for detection of small HCC prior to liver transplantation. Comparison with pathologic correlation Hepatology 38 2003 1034 1042
13. National Cancer Institute. US National Institute of Health. Available at: http://www.cancer.gov .
14. J. Bruix M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236